Obesity Accelerates T-Cell Leukemia in a Spontaneous Mouse Model.

Blood ◽  
2008 ◽  
Vol 112 (11) ◽  
pp. 1909-1909
Author(s):  
Jason P Yun ◽  
Lars Klemm ◽  
James W Behan ◽  
Markus Müschen ◽  
Steven D Mittelman

Abstract Obesity is associated with an increased risk of developing several types of cancer, including leukemia. As obesity is associated with alterations in a large number of physiological, physical, and lifestyle parameters, investigating this association is difficult in human studies. However, AKR/J mice are susceptible to diet-induced obesity and develop spontaneous T-cell leukemia starting at 5–6 months of age due to recombinant retroviruses that target thymocytes. Therefore, the present studies utilized this mouse model to test the following two hypotheses: 1. Diet induced obesity causes an accelerated presentation of T-cell leukemia in AKR/J mice, and 2. Obesity causes detectible alterations in T-cell maturation in AKR/J mice prior to the onset of leukemia. In Experiment 1, we determined the effect of obesity on the onset of T-cell leukemia by randomizing 24 male AKR/J mice to either a high fat (60% of calories from fat) or control diet (10% of calories from fat) at 4 weeks of age. Mice were classified as leukemic when they showed signs of clinical illness (labored breathing, dramatic weight loss, or lethargy) and they were sacrificed shortly thereafter. In Experiment 2, we characterized T-cell maturation in 24 additional male AKR/J mice randomized to either diet and sacrificed in groups of 3 at various time points prior to leukemia development. At sacrifice, thymuses were weighed and thymocytes analyzed by FACS for markers of T-cell differentiation, including CD4/ CD8 and T-cell receptor (TCR) αβ/γδ expression. By 6 weeks on the high-fat diet, mice in both experiments weighed significantly more than their littermates on the control diet (27.7±1.8 vs. 24.5±1.8g; p<0.001). This weight difference persisted throughout the study (53.8±2.8 vs. 45.5±3.9g at 6 months of age, p<0.001). In Experiment 1, obese AKR/ Js developed spontaneous thymoma and were sacrificed significantly earlier than their non-obese counterparts (Figure: median survival 237 vs. 310 days, p<0.05, log rank). In Experiment 2, we found no significant differences in thymus weights between diet groups (p=n.s. for all timepoints). Flow cytometry analyses of thymuses from the pre-leukemic mice, as characterized by CD4/CD8 and TCR αβ/γδ expression, demonstrated a characteristic pattern of maturing T-cell subgroups. This pattern was not different between the experimental groups. Thymuses from leukemic mice showed alterations in this pattern, characterized by expansion of specific populations (e.g. CD4/CD8 −/−), which differed from mouse to mouse. Again, diet group did not appear to affect which population predominated in the leukemic mice. These findings demonstrate that obesity accelerates spontaneous T-cell leukemia in the AKR/J mouse. However, diet-induced obesity does not appear to affect T-cell maturation prior to the onset of leukemia, at least not as defined by expression patterns CD4, CD8, and TCR αβ/γδ. Neither does obesity appear to promote the outgrowth of a specific leukemia population. Thus, the mechanism whereby obesity accelerates T-cell leukemia remains unclear. It is possible that obesity affects some other stage of leukemogenesis, such as affecting retroviral recombination or accelerating the proliferation of leukemia cells after they are transformed, but further work is needed to address this. Figure Figure

2019 ◽  
Vol 19 ◽  
pp. 100257 ◽  
Author(s):  
Nicole A. Kohart ◽  
Said M. Elshafae ◽  
Wachirapan Supsahvad ◽  
Aylin Alasonyalilar-Demirer ◽  
Amanda R. Panfil ◽  
...  

Blood ◽  
1989 ◽  
Vol 74 (1) ◽  
pp. 388-394 ◽  
Author(s):  
YC Chen ◽  
CH Wang ◽  
IJ Su ◽  
CY Hu ◽  
MJ Chou ◽  
...  

Abstract Among 354 adult patients with either hematological malignancy or aplastic anemia, eight were positive for anti-HTLV-I antibodies; six of eight had received multiple transfusions. There was an approximately 3.5-fold increase (P less than .001) of HTLV-I seropositivity in the patients with hematologic disease (8 of 354, 2.23%) compared to the healthy adults older than 20 years (34 of 5252, .65%). Two hematological patients, one with Hodgkin's disease and one with acute promyelocytic leukemia, were found to be positive for HTLV-I, and developed and died of adult T-cell leukemia/lymphoma (ATL) subsequently. Both were long-term survivors of the primary disease and had received multiple transfusions. The latent period from blood transfusion to onset of ATL was 6 months and 11 years, respectively. Immunocompromised patients, who were seropositive for HTLV-I, may be at increased risk for ATL compared to healthy carriers of HTLV-I, and the latent period may be shorter.


Blood ◽  
2010 ◽  
Vol 115 (10) ◽  
pp. 2118-2118
Author(s):  
Jumpei Yamazaki ◽  
Takuo Mizukami ◽  
William W. Hall ◽  
Isao Hamaguchi

Leukemia ◽  
2002 ◽  
Vol 16 (9) ◽  
pp. 1881-1882 ◽  
Author(s):  
J Miyagi ◽  
M Masuda ◽  
H Uezato ◽  
T Sawada ◽  
T Miyakuni ◽  
...  

2007 ◽  
Vol 67 (24) ◽  
pp. 11859-11866 ◽  
Author(s):  
S. T. Shu ◽  
M. V.P. Nadella ◽  
W. P. Dirksen ◽  
S. A. Fernandez ◽  
N. K. Thudi ◽  
...  

2005 ◽  
Vol 26 (8) ◽  
pp. 1382-1388 ◽  
Author(s):  
Takeo Ohsugi ◽  
Ryouichi Horie ◽  
Toshio Kumasaka ◽  
Akira Ishida ◽  
Takaomi Ishida ◽  
...  

2020 ◽  
Author(s):  
Lisa. S. Robison ◽  
Olivia J. Gannon ◽  
Melissa A. Thomas ◽  
Abigail E. Salinero ◽  
Charly Abi-Ghanem ◽  
...  

AbstractHypothalamic dysfunction occurs early in the clinical course of Alzheimer’s disease (AD), likely contributing to disturbances in feeding behavior and metabolic function that are often observable years prior to the onset of cognitive symptoms. Late-life weight loss and low BMI are associated with increased risk of dementia and faster progression of disease. However, high fat diet and metabolic disease (e.g. obesity, type 2 diabetes), particularly in mid-life, are associated with increased risk of AD, as well as exacerbated AD pathology and behavioral deficits in animal models. In the current study, we explored possible relationships between hypothalamic function, diet/metabolic status, and AD. Considering the sex bias in AD, with women representing two-thirds of AD patients, we sought to determine whether these relationships vary by sex. WT and 3xTg-AD male and female mice were fed a control (10% fat) or high fat (HF; 60% diet) diet from ~3-7 months of age, then tested for metabolic and hypothalamic disturbances. On control diet, male 3xTg-AD mice displayed decreased body weight, reduced fat mass, hypoleptinemia, and mild systemic inflammation, as well as increased expression of gliosis- and inflammation-related genes in the hypothalamus (Iba1, GFAP, TNF-α, IL-1β). In contrast, female 3xTg-AD mice on control diet displayed metabolic disturbances opposite that of 3xTg-AD males (increased body and fat mass, impaired glucose tolerance). HF diet resulted in expected metabolic alterations across groups (increased body and fat mass; glucose intolerance; increased plasma insulin and leptin, decreased ghrelin; nonalcoholic fatty liver disease-related pathology). HF diet resulted in the greatest weight gain, adiposity, and glucose intolerance in 3xTg-AD females, which were associated with markedly increased hypothalamic expression of GFAP and IL-1β, as well as GFAP labeling in several hypothalamic nuclei that regulate energy balance. In contrast, HF diet increased diabetes markers and systemic inflammation preferentially in AD males but did not exacerbate hypothalamic inflammation in this group. These findings provide further evidence for the roles of hypothalamic and metabolic dysfunction in AD, which in the 3xTg-AD mouse model appears to be dependent on both sex and diet.


PLoS ONE ◽  
2021 ◽  
Vol 16 (8) ◽  
pp. e0256320
Author(s):  
Yanuar Rahmat Fauzi ◽  
Shingo Nakahata ◽  
Syahrul Chilmi ◽  
Tomonaga Ichikawa ◽  
Phawut Nueangphuet ◽  
...  

Adult T-cell leukemia/lymphoma (ATLL) originates from human T-cell leukemia virus type 1 (HTLV-1) infection due to the activation of the nuclear factor-κB (NF-κB) signaling pathway to maintain proliferation and survival. An important mechanism of the activated NF-κB signaling pathway in ATLL is the activation of the macroautophagy (herafter referred to as autophagy in the remainder of this manuscript)-lysosomal degradation of p47 (NSFL1C), a negative regulator of the NF-κB pathway. Therefore, we considered the use of chloroquine (CQ) or hydroxychloroquine (HCQ) (CQ/HCQ) as an autophagy inhibitor to treat ATLL; these drugs were originally approved by the FDA as antimalarial drugs and have recently been used to treat autoimmune diseases, such as systemic lupus erythematosus (SLE). In this paper, we determined the therapeutic efficacy of CQ/HCQ, as NF-κB inhibitors, in ATLL mediated by blockade of p47 degradation. Administration of CQ/HCQ to ATLL cell lines and primary ATLL cells induced cell growth inhibition in a dose-dependent manner, and the majority of cells underwent apoptosis after CQ administration. As to the molecular mechanism, autophagy was inhibited in CQ-treated ATLL cells, and activation of the NF-κB pathway was suppressed with the restoration of the p47 level. When the antitumor effect of CQ/HCQ was examined using immunodeficient mice transplanted with ATLL cell lines, CQ/HCQ significantly suppressed tumor growth and improved the survival rate in the ATLL xenograft mouse model. Importantly, HCQ selectively induced ATLL cell death in the ATLL xenograft mouse model at the dose used to treat SLE. Taken together, our results suggest that the inhibition of autophagy by CQ/HCQ may become a novel and effective strategy for the treatment of ATLL.


Blood ◽  
1989 ◽  
Vol 74 (1) ◽  
pp. 388-394
Author(s):  
YC Chen ◽  
CH Wang ◽  
IJ Su ◽  
CY Hu ◽  
MJ Chou ◽  
...  

Among 354 adult patients with either hematological malignancy or aplastic anemia, eight were positive for anti-HTLV-I antibodies; six of eight had received multiple transfusions. There was an approximately 3.5-fold increase (P less than .001) of HTLV-I seropositivity in the patients with hematologic disease (8 of 354, 2.23%) compared to the healthy adults older than 20 years (34 of 5252, .65%). Two hematological patients, one with Hodgkin's disease and one with acute promyelocytic leukemia, were found to be positive for HTLV-I, and developed and died of adult T-cell leukemia/lymphoma (ATL) subsequently. Both were long-term survivors of the primary disease and had received multiple transfusions. The latent period from blood transfusion to onset of ATL was 6 months and 11 years, respectively. Immunocompromised patients, who were seropositive for HTLV-I, may be at increased risk for ATL compared to healthy carriers of HTLV-I, and the latent period may be shorter.


Retrovirology ◽  
2011 ◽  
Vol 8 (Suppl 1) ◽  
pp. A9 ◽  
Author(s):  
Tadaki Suzuki ◽  
Akiko Okayama ◽  
Takahiro Tsuji ◽  
Akihide Ryo ◽  
Hisashi Hirano ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document